NMDA受体
神经科学
兴奋毒性
伊芬普地尔
离子通道
受体
酸敏离子通道
海马结构
生物
兴奋性突触后电位
神经传递
细胞生物学
抑制性突触后电位
生物化学
作者
Chunlei Ma,Hui Sun,Yang Liu,Xingtao Wang,Su Gao,Xiaowen Chen,Zhiyuan Ma,Guihua Wang,Zhen Shi,Qingyin Zheng
出处
期刊:Neuroscience
[Elsevier BV]
日期:2019-03-26
卷期号:406: 389-404
被引量:14
标识
DOI:10.1016/j.neuroscience.2019.03.044
摘要
The over-activation of N-methyl-D-aspartate receptors (NMDARs) is the main cause of neuronal death in brain ischemia. Both the NMDAR and the Acid-sensing ion channel 1a (ASIC1a) are present in the postsynaptic membrane of the central nervous system (CNS) and participate in physiological and pathological processes. However, the specific role played by ASIC1a in these processes remains elusive. We hypothesize that NMDARs are the primary mediators of normal synaptic transmission and excitatory neuronal death, while ASIC1a plays a modulatory role in facilitating NMDAR function. Using various experimental approaches including patch-clamp recordings on hippocampal slices and CHO cells, primary cultures of hippocampal neurons, calcium imaging, Western blot, cDNA transfection studies, and transient middle cerebral artery occlusion (tMCAO) mouse models, we demonstrate that stimulation of ASIC1a facilitates NMDAR function and inhibition of ASIC1a suppresses NMDAR over-activation. One of our key findings is that activation of ASIC1a selectively facilitates the NR1/NR2A/NR2B triheteromeric subtype of NMDAR currents. In accordance, inhibition of ASIC1a profoundly reduced the NMDAR-mediated EPSCs in older mouse brains, which are known to express much higher levels of triheteromeric NMDARs than younger brains. Furthermore, brain infarct sizes were reduced by a greater degree in older mice compared to younger ones when ASIC1a activity was suppressed. These data suggest that ASIC1a activity selectively enhances the function of triheteromeric NMDARs and exacerbates ischemic neuronal death especially in older animal brains. We propose ASIC1a as a novel therapeutic target for preventing and reducing the detrimental effect of brain ischemia in humans.
科研通智能强力驱动
Strongly Powered by AbleSci AI